Latest radiation therapy Stories
PALO ALTO, Calif., Nov. 5, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is scheduled to present at Lazard Capital Markets 9(th) Annual Healthcare Conference at 1:30 p.m. ET on Tuesday, November 13, at the Pierre Hotel in New York City. Participating executives will be Dow Wilson, CEO, and Spencer Sias, vice president of investor relations and corporate communications. The presentation will focus on the company's growth opportunities in radiation oncology, X-ray imaging,...
PALO ALTO, Calif., Nov. 5, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is scheduled to present at Jefferies 2012 Global Healthcare Conference at 10:40 a.m. GMT on Thursday, November 15, at the Waldorf Hilton in London. Participating executives will be Spencer Sias, vice president of investor relations and corporate communications, and Neil Madle, director of investor relations Europe. The presentation will focus on the company's growth opportunities in radiation...
SUNNYVALE, Calif., Nov. 1, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife(®) M6((TM)) Series. The CyberKnife M6 Series features expanded clinical capabilities, reduced treatment times and an enhanced patient experience. The new CyberKnife M6 FIM and FM Systems, featuring the InCise(TM) Multileaf...
BOSTON, Oct. 31, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) highlighted the company's technologies for the non-invasive treatment of lung cancer at the 54(th) annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston this week. Many of Varian's cancer treatment systems can be utilized for attacking lung tumors--which often move during treatment--very precisely, with carefully-shaped, high dose X-ray beams. "Our latest treatment systems have...
Conditions reporting system helps foster culture of safety Documenting adverse events improves perceptions of safety and may decrease incidents in multi-site clinical practices, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania. The results of the year-long study, which focused on the Radiation Oncology department's workflow, show a strong correlation between the implementation of a Conditions Reporting System and increasingly...
BOSTON, Oct. 31, 2012 /PRNewswire/ -- The American Board of Radiology Foundation (ABRF) and Varian Medical Systems (NYSE: VAR) today announce that Varian is awarding a $100,000 grant to the ABRF to establish a national brachytherapy registry. The new registry, which is the first such nationwide modality-based project in radiation oncology, is linked to the American Board of Radiology's (ABR's) Innovation Pathway in Maintenance of Certification (MOC) for Focused Practice Recognition of...
CLEVELAND, Oct. 31, 2012 /PRNewswire/ -- A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive treatment technique may represent a potential new non-surgical option for patients with this deadly disease who have limited treatment options. Rod Ellis, MD, lead author of the study along with Lee Ponsky, MD, who...
Two MD Anderson-led studies conclude that patients' urinary, bowel function safe-guarded Two studies led by The University of Texas MD Anderson Cancer Center have found that proton therapy preserves the quality of life, specifically urinary and bowel function, in men treated with this targeted radiation modality for prostate cancer. Both studies, led by Andrew K. Lee, M.D., M.P.H., associate professor in MD Anderson's Department of Radiation Oncology, will be presented in a poster...
An oral rinse of the antidepressant doxepin significantly eased pain associated with oral mucositis in patients receiving radiation therapy for cancers of the head and neck, a study led by Mayo Clinic found. The findings were presented at the American Society for Radiation Oncology annual meeting in Boston. MULTIMEDIA ALERT: A video interview with Dr. Miller is available for journalists to download on the Mayo Clinic News Network. "Oral mucositis or mouth sores is a painful and...
BOSTON, Oct. 30, 2012 /PRNewswire/ -- Elekta activities at the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO) raised a total of $52,200 for Facing Cancer Together (FCT), a greater-Boston area nonprofit organization that guides and empowers individuals through the challenges of cancer. FCT offers a range of services and professionally facilitated programs, including support groups, expressive arts programming and mind-body wellness groups. Massachusetts is...
